Literature DB >> 15466368

Structures and biological activity of phosphorylated dihydroceramides of Porphyromonas gingivalis.

Frank C Nichols1, Birgit Riep, JiYoung Mun, Martha D Morton, Mike T Bojarski, Floyd E Dewhirst, Michael B Smith.   

Abstract

Porphyromonas gingivalis, a recognized periodontal pathogen, synthesizes free ceramides as well as other phosphorylated ceramide lipids. The purpose of this study was to separate complex lipids of P. gingivalis by high-performance liquid chromatography (HPLC) and determine the structures and biological activities of the major ceramide classes. Using gas chromatography-mass spectrometry, electrospray tandem mass spectrometry (ESI-MS/MS) and NMR analyses, three major classes of dihydroceramides were identified in specific HPLC fractions, with all classes containing the same dihydroceramide base structures (3-OH isoC(17:0) in amide linkage to saturated long-chain bases of 17, 18, or 19 carbons). The free dihydroceramide class recovered in HPLC fractions 7-8 revealed little biological activity. HPLC fraction 20 dihydroceramides, substituted with 1-O-phosphoglycerol and isoC(15:0) linked to the hydroxyl of 3-OH isoC(17:0), significantly potentiated interleukin-1beta (IL-1beta)-mediated prostaglandin secretion and produced marked alterations in fibroblast morphology. HPLC fraction 28 dihydroceramides, substituted with 1-O-phosphoethanolamine, demonstrated little capacity to potentiate IL-1beta-mediated prostaglandin secretion. The novel phosphorylated dihydroceramides synthesized by P. gingivalis demonstrate varying biological activities based on the phosphorylated head group substitution and/or the addition of esterified fatty acid. These results also demonstrate the strong virulence capacity of phosphoglycerol dihydroceramides of P. gingivalis to promote inflammatory factor secretion from IL-1beta-treated fibroblasts and to produce marked alterations in cell morphology in culture.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466368     DOI: 10.1194/jlr.M400278-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  36 in total

1.  Free lipid A isolated from Porphyromonas gingivalis lipopolysaccharide is contaminated with phosphorylated dihydroceramide lipids: recovery in diseased dental samples.

Authors:  Frank C Nichols; Bekim Bajrami; Robert B Clark; William Housley; Xudong Yao
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Serine dipeptide lipids of Porphyromonas gingivalis inhibit osteoblast differentiation: Relationship to Toll-like receptor 2.

Authors:  Yu-Hsiung Wang; Reza Nemati; Emily Anstadt; Yaling Liu; Young Son; Qiang Zhu; Xudong Yao; Robert B Clark; David W Rowe; Frank C Nichols
Journal:  Bone       Date:  2015-09-25       Impact factor: 4.398

Review 3.  Sphingolipidomics: methods for the comprehensive analysis of sphingolipids.

Authors:  Christopher A Haynes; Jeremy C Allegood; Hyejung Park; M Cameron Sullards
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-12-31       Impact factor: 3.205

4.  Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor.

Authors:  Hiroyuki Kanzaki; Alexandru Movila; Rayyan Kayal; Marcelo H Napimoga; Kenji Egashira; Floyd Dewhirst; Hajime Sasaki; Mohammed Howait; Ayman Al-Dharrab; Abdulghani Mira; Xiaozhe Han; Martin A Taubman; Frank C Nichols; Toshihisa Kawai
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-01-31       Impact factor: 4.698

5.  Protein Analysis of Sapienic Acid-Treated Porphyromonas gingivalis Suggests Differential Regulation of Multiple Metabolic Pathways.

Authors:  Carol L Fischer; Deborah V Dawson; Derek R Blanchette; David R Drake; Philip W Wertz; Kim A Brogden
Journal:  J Bacteriol       Date:  2015-10-19       Impact factor: 3.490

6.  Biologic activity of porphyromonas endodontalis complex lipids.

Authors:  Christopher S Mirucki; Mehran Abedi; Jin Jiang; Qiang Zhu; Yu-Hsiung Wang; Kamran E Safavi; Robert B Clark; Frank C Nichols
Journal:  J Endod       Date:  2014-04-13       Impact factor: 4.171

7.  Convergent synthesis of a deuterium-labeled serine dipeptide lipid for analysis of biological samples.

Authors:  Christopher Dietz; Robert B Clark; Frank C Nichols; Michael B Smith
Journal:  J Labelled Comp Radiopharm       Date:  2017-04-16       Impact factor: 1.921

8.  Porphyromonas gingivalis Sphingolipid Synthesis Limits the Host Inflammatory Response.

Authors:  F G Rocha; Z D Moye; G Ottenberg; P Tang; D J Campopiano; F C Gibson; M E Davey
Journal:  J Dent Res       Date:  2020-02-27       Impact factor: 6.116

9.  A novel class of lipoprotein lipase-sensitive molecules mediates Toll-like receptor 2 activation by Porphyromonas gingivalis.

Authors:  Sumita Jain; Stephen R Coats; Ana M Chang; Richard P Darveau
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

10.  A novel phosphoglycerol serine-glycine lipodipeptide of Porphyromonas gingivalis is a TLR2 ligand.

Authors:  Frank C Nichols; Robert B Clark; Mark W Maciejewski; Anthony A Provatas; Jeremy L Balsbaugh; Floyd E Dewhirst; Michael B Smith; Amanda Rahmlow
Journal:  J Lipid Res       Date:  2020-09-10       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.